Ajay Devgn challenges FDA show-cause notice in Bombay High Court
The actor alleges arbitrary action regarding surrogate advertising for Vimal Elaichi and challenges the validity of Food Safety Regulations.

Ajay Devgn has approached the Bombay High Court to challenge a show-cause notice issued by the FDA regarding Vimal Elaichi advertisements. The actor alleges that the action taken against him in a surrogate advertising case is arbitrary.
The FDA issued show-cause notices to Ajay Devgn, Shah Rukh Khan, and Tiger Shroff in August. The department linked the brand to the sale of gutkha and pan masala, which are products the State does not allow.
Additionally, the petition challenges the constitutional validity of certain provisions of the Food Safety Regulations.
FDA Commissioner Tukaram Mundhe said on Friday, October 30, 2026, that proceedings against the three actors have ended. The matter will now go before the Joint Commissioner for adjudication. Mundhe stated that the adjudication proceedings may be heard by next week.
A division bench of Chief Justice Mahesh Chandra Tripathi and Justice Advait Sethna may hear the petition on November 4. This follows a September 14 decision by the Delhi High Court, which refused to entertain a plea against the Maharashtra FDA notices and dismissed a plea by PB Agro LLP. The Delhi High Court observed that courts in Maharashtra were the proper forum for such a challenge.
Key facts
- Ajay Devgn challenged the FDA show-cause notice in the Bombay High Court.
- The FDA issued notices to Ajay Devgn, Shah Rukh Khan, and Tiger Shroff in August.
- FDA Commissioner Tukaram Mundhe said proceedings would move to the Joint Commissioner for adjudication.
- The Bombay High Court may hear the petition on November 4.
Three perspectives
Neutral
Ajay Devgn has filed a petition in the Bombay High Court against show-cause notices issued by the FDA regarding Vimal Elaichi advertisements.
Positive
The FDA Commissioner stated that the current proceedings have ended and the matter will proceed to adjudication before the Joint Commissioner.
Negative
The FDA linked the brand to the sale of gutkha and pan masala, products that the State does not allow.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.